Perspective on Circulating Tumor Cell Clusters: Why It Takes a Village to Metastasize von Giuliano, Mario, Shaikh, Anum, Lo, Hin Ching, Arpino, Grazia, De Placido, Sabino, Zhang, Xiang H, Cristofanilli, Massimo, Schiff, Rachel, Trivedi, Meghana V

Volltext

Metastasis dormancy in estrogen receptor-positive breast cancer von Zhang, Xiang H-F, Giuliano, Mario, Trivedi, Meghana V, Schiff, Rachel, Osborne, C Kent

Volltext

Adherence to oral endocrine therapy in racial/ethnic minority patients with low socioeconomic status before and during the COVID-19 pandemic von Rahimi, Sama, Ononogbu, Onyebuchi, Mohan, Anjana, Moussa, Daniel, Abughosh, Susan, Trivedi, Meghana V.

Volltext

Immunomodulator adherence in multiple myeloma patients with lower socioeconomic status: a retrospective study von Ononogbu, Onyebuchi, Akindele, Oyinkansola, Yazdanfard, Sahar, Fatima, Bilqees, Abughosh, Susan, Trivedi, Meghana V.

Volltext

A novel role of ADGRF1 (GPR110) in promoting cellular quiescence and chemoresistance in human epidermal growth factor receptor 2‐positive breast cancer von Abdulkareem, Noor Mazin, Bhat, Raksha, Qin, Lanfang, Vasaikar, Suhas, Gopinathan, Ambily, Mitchell, Tamika, Shea, Martin J., Nanda, Sarmistha, Thangavel, Hariprasad, Zhang, Bing, De Angelis, Carmine, Schiff, Rachel, Trivedi, Meghana V.

Volltext

Dose-dependent relation between metformin and the risk of hormone receptor-positive, her2-negative breast cancer among postmenopausal women with type-2 diabetes von Chikermane, Soumya G., Sharma, Manvi, Abughosh, Susan M., Aparasu, Rajender R., Trivedi, Meghana V., Johnson, Michael L.

Volltext

ADGRF1 promotes tumorigenesis via the activation of STAT3 pathway in HER2+ and triple‐negative breast cancers von Abdulkareem, Noor M., Bhat, Raksha, Trivedi, Meghana V.

Volltext

Cost Effectiveness of CDK4/6 Inhibitors in the First-Line Treatment of HR+/HER2− Metastatic Breast Cancer in Postmenopausal Women in the USA von Masurkar, Prajakta P., Damgacioglu, Haluk, Deshmukh, Ashish A., Trivedi, Meghana V.

Volltext

NPY1R exerts inhibitory action on estradiol-stimulated growth and predicts endocrine sensitivity and better survival in ER-positive breast cancer von Bhat, Raksha, Thangavel, Hariprasad, Abdulkareem, Noor Mazin, Vasaikar, Suhas, De Angelis, Carmine, Bae, Leon, Cataldo, Maria Letizia, Nanda, Sarmistha, Fu, Xiaoyong, Zhang, Bing, Schiff, Rachel, Trivedi, Meghana V.

Volltext

The changing role of ER in endocrine resistance von Nardone, Agostina, De Angelis, Carmine, Trivedi, Meghana V, Osborne, C. Kent, Schiff, Rachel

Volltext

Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational study von Buono, Giuseppe, Crispo, Anna, Giuliano, Mario, De Angelis, Carmine, Schettini, Francesco, Forestieri, Valeria, Lauria, Rossella, De Laurentiis, Michelino, De Placido, Pietro, Rea, Carmen Giusy, Pacilio, Carmen, Esposito, Emanuela, Grimaldi, Maria, Nocerino, Flavia, Porciello, Giuseppe, Giudice, Aldo, Amore, Alfonso, Minopoli, Anita, Botti, Gerardo, De Placido, Sabino, Trivedi, Meghana V., Arpino, Grazia

Volltext

Bidirectional Crosstalk between the Estrogen Receptor and Human Epidermal Growth Factor Receptor 2 Signaling Pathways in Breast Cancer: Molecular Basis and Clinical Implications von Giuliano, Mario, Trivedi, Meghana V., Schiff, Rachel

Volltext

High FOXA1 levels induce ER transcriptional reprogramming, a pro-metastatic secretome, and metastasis in endocrine-resistant breast cancer von Fu, Xiaoyong, Pereira, Resel, Liu, Chia-Chia, De Angelis, Carmine, Shea, Martin J., Nanda, Sarmistha, Qin, Lanfang, Mitchell, Tamika, Cataldo, Maria L., Veeraraghavan, Jamunarani, Sethunath, Vidyalakshmi, Giuliano, Mario, Gutierrez, Carolina, Győrffy, Balázs, Trivedi, Meghana V., Cohen, Ofir, Wagle, Nikhil, Nardone, Agostina, Jeselsohn, Rinath, Rimawi, Mothaffar F., Osborne, C. Kent, Schiff, Rachel

Volltext

Oral Endocrine Therapy Agent, Race/Ethnicity, and Time on Therapy Predict Adherence in Breast Cancer Patients in a Large Academic Institution von Hwang, Grace S., Paranjpe, Rutugandha, Opsomer, Carine, Lu, Kelvin, Abajue, Uzoamaka, Abughosh, Susan, Zaghloul, Hanna, Trivedi, Meghana V.

Volltext

Racial and ethnic differences in capecitabine toxicity in patients with gastrointestinal tract cancers von Brazelton, Alicia, Yande, Soham, Pope, Rita, Johnson, Michael L, Musher, Benjamin, Trivedi, Meghana V

Volltext

Ribociclib in HR+/HER2− Advanced or Metastatic Breast Cancer Patients von Rascon, Kaitlin, Flajc, Goran, De Angelis, Carmine, Liu, Xinli, Trivedi, Meghana V., Ekinci, Ekim

Volltext

Evaluation of the Predictive Role of Tumor Immune Infiltrate in Patients with HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2 Therapy without Chemotherapy von De Angelis, Carmine, Nagi, Chandandeep, Hoyt, Cliff C, Liu, Linying, Roman, Kristin, Wang, Chichung, Zheng, Yi, Veeraraghavan, Jamunarani, Sethunath, Vidyalakshmi, Nuciforo, Paolo, Wang, Tao, Tsimelzon, Anna, Mao, Sufeng, Hilsenbeck, Susan G, Trivedi, Meghana V, Cataldo, Maria Letizia, Pavlick, Anne, Wolff, Antonio C, Weigelt, Britta, Reis-Filho, Jorge S, Prat, Aleix, Gutierrez, Carolina, Osborne, Charles Kent, Rimawi, Mothaffar F, Schiff, Rachel

Volltext

Vaginal estrogen products in hormone receptor-positive breast cancer patients on aromatase inhibitor therapy von Sulaica, Elisabeth, Han, Tiffany, Wang, Weiqun, Bhat, Raksha, Trivedi, Meghana V., Niravath, Polly

Volltext

Neratinib in HER2-Positive Breast Cancer Patients von Paranjpe, Rutugandha, Basatneh, Dima, Tao, Gabriel, De Angelis, Carmine, Noormohammed, Sobia, Ekinci, Ekim, Abughosh, Susan, Ghose, Romi, Trivedi, Meghana V.

Volltext

The risk of febrile neutropenia and need for G-CSF primary prophylaxis with the docetaxel and cyclophosphamide regimen in early-stage breast cancer patients: a meta-analysis von Do, Tran, Medhekar, Rohan, Bhat, Raksha, Chen, Hua, Niravath, Polly, Trivedi, Meghana V.

Volltext